Minimal change disease with interferon-beta therapy for relapsing remitting multiple sclerosis | Zendy

Ananthakrishnapuram Aravindan | Zendy; J. Yong | Zendy; Murray C. Killingsworth | Zendy; Michael Suranyi | Zendy; Jeffrey G. Wong | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Minimal change disease with interferon-beta therapy for relapsing remitting multiple sclerosis

Author(s) -

Ananthakrishnapuram Aravindan,

J. Yong,

Murray C. Killingsworth,

Michael Suranyi,

Jeffrey G. Wong

Publication year - 2009

Publication title -

clinical kidney journal

Language(s) - English

Resource type - Journals

eISSN - 2048-8513

pISSN - 2048-8505

DOI - 10.1093/ndtplus/sfp162

Subject(s) - medicine , multiple sclerosis , relapsing remitting , interferon beta , interferon , nephrotic syndrome , beta (programming language) , disease , immunology , computer science , programming language

Interferon beta is widely used for the treatment of relapsing and remitting multiple sclerosis. Renal side effects including nephrotic syndrome have been increasingly described with interferon beta treatment. We describe an illustrative case of a patient who developed severe nephrotic syndrome due to minimal change disease in association with interferon beta therapy and showed partial remission following cessation of interferon beta and treatment with corticosteroids.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research